|
Originally published In Press as doi:10.1074/jbc.M006606200 on September 28, 2000
J. Biol. Chem., Vol. 275, Issue 51, 40187-40194, December 22, 2000
Regulation of a Ca2+-sensitive Adenylyl Cyclase in an
Excitable Cell
ROLE OF VOLTAGE-GATED VERSUS CAPACITATIVE
Ca2+ ENTRY*
Kent A.
Fagan ,
Robert A.
Graf ,
Shawna
Tolman§,
Jerome
Schaack§, and
Dermot M. F.
Cooper ¶
From the Departments of Pharmacology and
§ Microbiology, University of Colorado Health Sciences
Center, Denver, Colorado 80262
Received for publication, July 24, 2000, and in revised form, September 20, 2000
 |
ABSTRACT |
In nonexcitable cells, we had previously
established that Ca2+-sensitive adenylyl cyclases,
whether expressed endogenously or heterologously, were regulated
exclusively by capacitative Ca2+ entry (Fagan, K. A.,
Mahey, R. and Cooper, D. M. F. (1996) J. Biol.
Chem. 271, 12438-12444; Fagan, K. A., Mons, N., and Cooper, D. M. F. (1998) J. Biol. Chem. 273, 9297-9305). Relatively little is known about how these enzymes are
regulated by Ca2+ in excitable cells, where they
predominate. Furthermore, no effort has been made to determine whether
the prominent voltage-gated Ca2+ entry, which typifies
excitable cells, overwhelms the effect of any capacitative
Ca2+ entry that may occur. In the present study, we placed
the Ca2+-stimulable, adenylyl cyclase type VIII in an
adenovirus vector to optimize its expression in the pituitary-derived
GH4C1 cell line. In these cells, a modest
degree of capacitative Ca2+ entry could be discerned in the
face of a dramatic voltage-gated Ca2+ entry. Nevertheless,
both modes of Ca2+ entry were equally efficacious at
stimulating adenylyl cyclase. A striking release of Ca2+
from intracellular stores, triggered either by ionophore or
thyrotrophin-releasing hormone, was incapable of stimulating the
adenylyl cyclase. It thus appears as though the intimate colocalization
of adenylyl cyclase with capacitative Ca2+ entry channels
is an intrinsic property of these molecules, regardless of
whether they are expressed in excitable or nonexcitable cells.
 |
INTRODUCTION |
Ca2+-sensitive adenylyl cyclases provide a means of
coordinating the activities of the two major signaling systems of cAMP
and Ca2+ (1). The fact that these cyclases are regulated by
Ca2+ entering the cells ensures an acute response of the
cAMP-generating system to the elevation of
[Ca2+]i.1
In nonexcitable cells, we have previously shown a strict dependence for
capacitative Ca2+ entry (CCE) as the mode of
[Ca2+]i elevation that would regulate
Ca2+-sensitive adenylyl cyclases, whether they were
expressed endogenously or heterologously (2, 3). In particular,
Ca2+ released from internal stores by any mechanism was
unable to regulate adenylyl cyclase activity (4), whereas
Ca2+ entering via CCE modulated cAMP synthesis positively
or negatively, depending on the adenylyl cyclase species expressed (2,
3). These findings have now been extended to other nonexcitable cell systems (5-7). Although the endogenous Ca2+-stimulable
adenylyl cyclase of cerebellar granule cells (8) and of hippocampal
slices (9) is stimulated by Ca2+ influx through
voltage-gated calcium channels (VGCCs), it is not known whether
adenylyl cyclases in excitable cells are as discriminating as those
expressed in nonexcitable cells for the nature of the Ca2+
rise to which they respond. In the present study, the
Ca2+-stimulable ACVIII was placed in an adenovirus vector
to provide efficient expression in the excitable, anterior
pituitary-derived tumor line, GH4C1.
GH4C1 cells are spontaneously electrically active and express VGCCs that give rise to prominent intracellular rises in [Ca2+]i upon membrane depolarization
(10). They also express TRH receptors coupled to phospholipase C that
elevate [Ca2+]i both by inositol
1,4,5-trisphosphate-linked mechanisms and by modifying the
activity of VGCCs (11). It seemed possible that
GH4C1 cells, like most neuronal cells, might
not display prominent CCE; however, if CCE was detectable, the
opportunity would be provided to determine whether any selectivity was
displayed in the regulation of the adenylyl cyclase for either type of
[Ca2+]i rise in the same cell type.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Thapsigargin and forskolin were from Calbiochem.
[2-3H]Adenine and [ -32P]ATP were
obtained from Amersham Pharmacia Biotech. Fura-2/AM and pluronic acid
were from Molecular Probes, Inc. (Eugene, OR). Other reagents were from Sigma.
Cells and Viruses--
Viruses were constructed and propagated
using HEK 293 cells, a human embryonic kidney cell line transformed by
and expressing high levels of Ad5 E1A and E1B proteins (12). The virus
used for recombination was Ad5dl327Bst -gal,
which encodes LacZ in place of the E1A and E1B genes and permits
color screening for recombinant viruses (13).
Ad5dl327Bst -gal was purified after infection
of HEK 293 cells at maximal cytopathic effect, releasing the virus from
the concentrated cell pellet by three cycles of rapid freezing and
thawing; the cell debris was pelleted and re-extracted twice by
resuspension in a small volume of phosphate-buffered saline followed by
rapid freezing and thawing and pelleting of the cell debris. The
supernatants were combined and banded for 50 min at 36,000 rpm using a
CsCl step gradient consisting of 1 ml of 1.4 g/ml CsCl in
phosphate-buffered saline and 1.5 ml of 1.25 g/ml CsCl in
phosphate-buffered saline in a SW40 rotor. The virion band was
collected by side puncture, diluted in 1.35 g/ml CsCl in
phosphate-buffered saline, and rebanded for 3 h at 65,000 rpm in a
VTi65 rotor. The virion band was again collected by side puncture. To
prepare Ad5dl327Bst -gal-terminal protein (TP)
complex, the sample was diluted in 4 M guanidine-HCl and 2.8 M CsCl (14) and banded overnight at 65,000 rpm using a
VTi65 rotor. The gradient was fractionated by dripping and fractions containing DNA were identified by agarose gel electrophoresis of
aliquots. DNA-containing fractions were combined and dialyzed versus 6 changes of 2 liters each of 10 mM
Tris-HCl, pH 8.0, 10 mM NaCl, and 0.2 mM EDTA
at 4 °C. The presence of TP on the DNA greatly increases the
infectivity after transfection (15), presumably due to both increased
nuclear uptake facilitated by the nuclear localization signal in TP and
protection of the DNA from degradation. Ad5dl327Bst -gal-TP was digested with
BstBI. For analysis of the completion of digestion, an
aliquot was digested with proteinase K before agarose gel
electrophoresis. BstBI-digested
Ad5dl327Bst -gal-TP was aliquoted and stored
at 20 °C.
Plasmid Construction--
A cDNA encoding ACVIII was cloned
into pACCMV under the control of the cytomegalovirus major immediate
early promoter (CMV promoter; Ref. 16) to yield pACCMV-ACVIII, which
places expression under the control of the CMV promoter, and into the
plasmid pXC15E1A#12 to yield pXC15E1A-ACVIII, which places expression
under the control of the adenovirus type 5 E1A promoter.
pXC15E1A-ACVIII was further modified by insertion of a BstBI
adaptor in the SalI site between the 3' end of the ACVIII
coding sequence and the sequences encoding the intron and poly(A) sites
(which are contributed by the 3' end of the E1B gene) to generate
pXC15E1A-ACVIIIBst.
Transfections--
HEK 293 cells at approximately 70%
confluence were transfected using a modified calcium phosphate
procedure (17) using 6 µg of plasmid DNA and approximately 0.2 µg
of Ad5dl327Bst -gal-TP complex. Cells were
incubated with the transfection solution overnight before being fed
with fresh medium.
Construction of Adenovirus Transducing Vector Encoding
ACVIII--
Because cAMP is a prominent regulator of cell growth and
numerous cellular processes, it would be expected that adenylyl cyclase expression would be tightly regulated and constrained to low levels (18). Thus, whereas attempts were made to construct transducing viruses
placing ACVIII expression under the control of both the strong CMV
promoter and weaker E1A promoters, it was expected that the use of the
E1A promoter would yield a virus that directed expression at a level
closer to the normal level. The use of the E1A promoter was also
expected to make construction and growth of the virus easier because
high-level expression of the cyclase might be expected to alter
expression of a variety of genes and interfere specifically with
regulation of adenovirus gene expression (e.g., Refs.
19-22). In addition to being a generally weaker promoter than the CMV
promoter, the activity of the E1A promoter is inhibited by the high
level of E1A protein expressed in HEK 293 cells (23 and data not
shown). Attempts to introduce
pXC15E1A-ACVIII into BstBI-digested
Ad5dl327Bst -gal-TP by standard overlap
recombination (13, 24) were unsuccessful. As an alternative, ligation
of the modified plasmid, pXC15E1A-ACVIIIBst, with the
large, right arm of the adenovirus chromosome-TP complex was used. 6 µg of pXC15E1A#12-ACVIIIBst was digested with
BstBI to generate a ligation site for the viral arm and with
XmnI, which cleaves in the -lactamase coding sequence
within the plasmid vector backbone to leave a blunt end, to inhibit
recircularization of the plasmid as well as ligation to form
concatamers. The restriction enzyme-digested plasmid was ligated with
Ad5dl327Bst -gal-TP complex that had been
digested with BstBI. The ligation mix was used to transfect HEK 293 cells to generate the virus. It was expected that expression of
ACVIII during the transfection would be significantly reduced because
of the reduction in the number of ACVIII templates that contained
exon and poly(A) sequences. Furthermore, direct ligation with the
large arm of Ad5dl327Bst -gal-TP complex was
expected to efficiently introduce the E1A-ACVIII cassette into the
virus. Ligation to the large arm of adenovirus restores the intron and a poly(A) site provided by the 3' end of the E1B gene, thus ACVIII expression should be directed by the recombinant virus. Plaques were
purified from the transfection stock after serial dilution in HEK 293 cells and overlaying with Noble agar-containing medium and serum.
Plates were stained with neutral red and
5-bromo-4-chloro-3-indolyl- -D-pyranogalactoside 7 days
after infection, and clear plaques were picked on day 8. Plaques were
grown in HEK 293 cells and tested for the presence of the ACVIII gene
by polymerase chain reaction. A positive clone was grown in large
stock, purified by banding consecutively on CsCl step and isopycnic
gradients as indicated above, and dialyzed versus three
changes of 1 liter each of 135 mM NaCl, 10 mM
Tris-HCl, pH. 8.0, 1 mM MgCl2, and 50% (v/v)
glycerol at 4 °C. The virus particle concentration was determined by
reading absorbance at 260 nm, with 1 A260 unit
considered equivalent to 1012 particles. The
particle:plaque-forming unit ratio was approximately 100:1 for all preparations.
Cell Culture and Infection--
Rat anterior pituitary
GH4C1 cells were maintained in 13 ml of Ham's
F-10 medium (Life Technologies, Inc.) with 15% (v/v) horse serum and
2.5% fetal bovine serum (Gemini) in 75-cm2 flasks at
37 °C in a humidified atmosphere of 95% air and 5% CO2. 4 × 106 cells were plated on 100-mm
culture dishes for infection with the ACVIII construct. 48 h after
infection, cells were detached with phosphate-buffered saline
containing 0.03% EDTA and used immediately for measurement of cAMP
accumulation or [Ca2+]i. The expression of ACVIII
was optimized by varying the multiplicity of infection (m.o.i.).
GH4C1 cells were infected with m.o.i.s ranging
from 0 to 200 and assayed for their ability to be stimulated by
Ca2+. After activation of VGCCs, a m.o.i. of 100 and 200 resulted in a robust Ca2+ stimulation of the cyclase of
approximately 4- and 5-fold respectively. A m.o.i. of 100 was selected
for further experiments to conserve virus stocks.
Measurement of cAMP Accumulation--
cAMP accumulation in
intact cells was measured according to the method of Evans et
al. (25) as described previously (26), with some modifications.
GH4C1 cells on 100-mm culture dishes were
incubated in Ham's F-10 medium (90 min at 37 °C) containing [2-3H]adenine (20.0 µCi/dish) to label the ATP pool.
The cells were washed once and detached using phosphate-buffered saline
containing EDTA (0.03%). The cells were then resuspended in a
nominally Ca2+-free Krebs buffer containing 120 mM NaCl, 4.75 mM KCl, 1.44 mM MgSO4, 11 mM glucose, 25 mM HEPES,
and 0.1% bovine serum albumin (fraction V) adjusted to pH 7.4 with 2 M Tris base. The resuspended cells were aliquoted
(approximately 3 × 105 cells/tube) and used for cAMP
determination in triplicate assays. Experiments were carried out at
30 °C in the presence of the phosphodiesterase inhibitor
3-isobutyl-1-methylxanthine (IBMX, 100 µM), which was preincubated with the cells for 10 min before a 1-min assay. Unless indicated otherwise, forskolin (10 µM) was included in
each assay to increase the cAMP signal. Assays were terminated by the
addition of 10% (w/v, final concentration) trichloroacetic acid. The
[3H]ATP and [3H]cAMP content of the
supernatants was quantified according to the standard Dowex/alumina
methodology (27) as described previously (26). Accumulation of cAMP is
expressed as the percentage of conversion of [3H]ATP into
[3H]cAMP; means ± S.D. of triplicate determinations
are indicated.
[Ca2+]i
Measurements--
GH4C1 cells (10 × 106/ml) were loaded with Fura-2/AM (2 µM)
plus 0.02% pluronic acid in Ham's F-10 media (serum-free media containing 20 mM HEPES and 0.1% bovine serum albumin, pH
7.4) for 45 min at room temperature. The cells were then washed twice with the same media and resuspended at a concentration of 10 × 106 cells/ml. Aliquots (400 µl; 4 × 106
cells) were pelleted, resuspended in nominally Ca2+-free
Krebs buffer, and used for [Ca2+]i measurements
in a Perkin-Elmer LS50B spectrofluorometer. No differences were seen in
[Ca2+]i-traces from infected and uninfected
cells. Cell pretreatment with EGTA (0.1 mM) is
referred to as the Ca2+-free condition. The 340/380 nm
emission ratios were converted to [Ca2+] using the
standard formula (28).
 |
RESULTS |
The functional expression of ACVIII was determined by biochemical
assay. Because adenylyl cyclase type II, a Ca2+-insensitive
isoform, is the predominant mRNA in GH4C1
cells (29), the expression of ACVIII activity could be demonstrated
conclusively by an increase in cAMP accumulation in response to an
elevation in [Ca2+]i. The most robust means of
elevating [Ca2+]i in
GH4C1 cells is via VGCCs (30). Consequently, VGCCs were activated by membrane depolarization by increasing [K+]o in the presence or absence of extracellular
Ca2+ ([Ca2+]o). When assayed with
forskolin, control cells showed no response to VGCC-mediated
Ca2+ entry, whereas ACVIII-infected cells exhibited a
robust stimulation in cAMP accumulation upon Ca2+ entry,
yielding an approximately 3.5-fold stimulation compared with the
Ca2+-free condition (Fig.
1A). Vasoactive intestinal
peptide stimulation of the cyclase via s
activation could also be augmented approximately 2.5-fold by
VGCC-mediated Ca2+ entry (Fig. 1B). Therefore,
the use of an adenovirus construct to express ACVIII provided a simple
and efficient means of heterologously expressing this protein in this
excitable cell type.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 1.
Functional expression of ACVIII in
GH4C1 cells. GH4C1
cells were infected with the ACVIII/adenovirus construct (at a m.o.i.
of 100) 48 h before assay. cAMP accumulation was measured in
populations of GH4C1 cells as described under
"Experimental Procedures." A, uninfected (open
bars) and ACVIII-infected GH4C1 cells
(right-hatched bars) were pretreated with IBMX (100 µM) and maintained in Ca2+-free Krebs buffer.
cAMP accumulation was measured over a 1-min period starting with the
addition of forskolin (10 µM), KCl (20 mM),
and the presence or absence of [Ca2+]o (2 mM), as indicated. B, cAMP accumulation was
measured in GH4C1 cells infected with the
ACVIII/adenovirus as described above, in the presence of vasoactive
intestinal peptide (VIP; 200 nM), KCl (20 mM), and the presence or absence of
[Ca2+]o (2 mM), as indicated. Basal
cAMP accumulation values were 0.3 ± 0.02 and 0.43 ± 0.01 for uninfected and infected cells, respectively. Data are
representative of three similar experiments.
|
|
Little is known about the regulation of adenylyl cyclases by
VGCC-mediated Ca2+ entry in excitable cells. In
nonexcitable cells, we have previously established that
Ca2+ stimulation of heterologously expressed ACVIII occurs
exclusively via CCE. Therefore, we wanted to characterize more fully
the ability of VGCCs to regulate ACVIII expressed heterologously in an
excitable cell. The activity of VGCCs relies on the membrane potential, which is dictated, in part, by the K+ concentration in the
medium bathing the cells. The amount of Ca2+ entry after
membrane depolarization with varying [K+]o was
assessed (Fig. 2A).
Populations of Fura-2-loaded GH4C1 cells
were maintained in Ca2+-free Krebs buffer (which contains
4.75 mM KCl). At 300 s, the [K+]o was increased by the addition of KCl (0-20
mM) and CaCl2 (2 mM), which
resulted in a rapid, robust [Ca2+]i rise. The
magnitude of the peak [Ca2+]i rise ranged from
approximately 230 nM to approximately 1050 nM,
depending on the [K+]o. The apparently equivalent
[Ca2+]i rise elicited by 10 and 20 mM
KCl indicates maximal stimulation of the VGCCs by modest membrane
depolarization (indeed, addition of 40 mM KCl resulted in a
[Ca2+]i rise identical to that elicited by 20 mM KCl; data not shown).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of increasing
[K+]o on VGCC-mediated Ca2+ entry in
GH4C1 cells. A,
[Ca2+]i was determined in aliquots of 4 × 106 Fura-2-loaded GH4C1
cells as described under "Experimental Procedures." Cells were
maintained in nominally Ca2+-free Krebs buffer containing
IBMX (100 µM) before the addition of
[Ca2+]o (2 mM), along with varying
[KCl]o (a, 20 mM; b, 10 mM; c, 5 mM; d, 0 mM), at 300 s. B, cAMP accumulation was
measured in ACVIII-infected GH4C1 cells under
the same conditions as described above. Cells were assayed in the
presence of forskolin (10 µM), ± [Ca2+]o (2 mM), and varying
[KCl]o (5 mM, open bars; 10 mM, right-hatched bars; 20 mM, cross-hatched bars), as
indicated. Data are representative of three similar experiments.
|
|
The ability of the progressive [Ca2+]i rises
triggered by incremental [K+]o increases to
regulate the exogenously expressed ACVIII was next examined.
GH4C1 cells infected with the ACVIII virus were
incubated in Ca2+-free Krebs buffer. cAMP accumulation was
measured over a 1-min period starting with the addition of forskolin
and varying [KCl]o and [Ca2+]o as
indicated (Fig. 2B). In the absence of
[Ca2+]o, there was no effect of membrane
depolarization on cAMP accumulation. Inclusion of
[Ca2+]o (2 mM) increased cAMP
production at all [K+]o values, with an
approximately 2-fold stimulation in the 5 mM
[K+]o condition and an approximately 2.8-fold
stimulation for the 10 and 20 mM
[K+]o conditions. Thus, the observed
"plateau" in the ability of high [K+]o to
stimulate further Ca2+ entry was reflected in the
regulation of ACVIII. Note that the cAMP accumulation is measured over
the first minute after the addition of [Ca2+]o,
where the [Ca2+]i rises triggered by 10 and 20 mM [K+]o are very similar
(cf. Fig. 2A).
The above-mentioned findings showed that a Ca2+-sensitive
adenylyl cyclase could be regulated by Ca2+ entry through
VGCCs in excitable cells. Furthermore, the magnitude of the stimulation
mirrored the extent of Ca2+ entry. We have seen similar
results with CCE in nonexcitable cells. In excitable cells, the role of
CCE has been explored only sparingly in the face of the much more
pronounced [Ca2+]i rise generated by VGCCs.
However, we wondered whether CCE was present in excitable cells, if it
could also regulate ACVIII, and how this might compare with the
regulation by VGCC-mediated Ca2+ entry. CCE is activated by
depletion of intracellular Ca2+ stores using the
sarcoplasmic/endoplasmic Ca2+-ATPase inhibitor thapsigargin
(TG) (31). Treatment of the cells with TG resulted in a modest
[Ca2+]i rise (approximately 130 nM)
that returned toward baseline because the cells were in
Ca2+-free media (Fig.
3A). Addition of
[Ca2+]o, either 0.5 or 2 mM, resulted
in a rapid [Ca2+]i rise that reached a peak of
approximately 230 or 380 nM, respectively, within the time
course of the cAMP measurements. Although the
[Ca2+]i rise due to CCE was rather robust, it was
considerably smaller than the [Ca2+]i rise
generated by VGCC-mediated Ca2+ entry (Fig. 3B).
Depolarization of the cells with KCl (10 mM) in the
presence of either 0.5 or 2 mM
[Ca2+]o resulted in peak
[Ca2+]i rises of approximately 400 and 550 nM, respectively. Therefore, triggering of CCE by
intracellular Ca2+ store depletion resulted in a modest
[Ca2+]i rise compared with that arising from
VGCC-mediated Ca2+ entry. Next, the ability of CCE and
VGCC-mediated Ca2+ entry to stimulate ACVIII was compared.
Cells maintained in Ca2+-free Krebs buffer were treated
with TG 4 min before the addition of varying
[Ca2+]o (Fig. 3C). The stimulation of
ACVIII (approximately 3.5-fold) by CCE was apparent at low
[Ca2+]o (0.5 mM). Addition of higher
[Ca2+]o (2 mM) resulted in further
stimulation of ACVIII (approximately 5.2-fold). Comparing the ability
of CCE and VGCC-mediated Ca2+ entry to regulate ACVIII, it
was apparent that at higher [Ca2+]o, they were
very similar, with a slight difference observed at lower
[Ca2+]o. The ability of CCE and VGCC-mediated
Ca2+ entry to stimulate ACVIII similarly is somewhat
surprising in the light of the more robust Ca2+ entry
arising from VGCCs (cf. Fig. 3, A and
B).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Comparison of CCE and VGCC-mediated
Ca2+ entry and their effect on ACVIII-infected
GH4C1 cells. A-C,
[Ca2+]i and cAMP accumulation was determined in
GH4C1 cells as described under "Experimental
Procedures." A, cells were maintained in nominally
Ca2+-free Krebs buffer containing IBMX (100 µM) before the addition of TG (100 nM;
60 s) followed by the addition of [Ca2+]o
(a, 2 mM; b, 0.5 mM) at
300 s. B, cells were incubated in nominally
Ca2+-free Krebs buffer containing IBMX (100 µM) before the addition of KCl (10 mM) and
[Ca2+]o (a, 2 mM;
b, 0.5 mM) at 300 s. C, cAMP
accumulation was measured in ACVIII-infected
GH4C1 cells under the same conditions as
described above. Cells were assayed in the presence of forskolin (10 µM) and [Ca2+]o (0.5 or 2 mM, as indicated). CCE was stimulated with the prior
addition of TG (100 nM; open bars), whereas
VGCC-mediated Ca2+ entry was triggered with the concomitant
addition of KCl (10 mM; hatched bars). Data are
representative of two similar experiments.
|
|
The clear demonstration of CCE in GH4C1 cells
can be difficult because individual GH4C1 cells
demonstrate spontaneous Ca2+ oscillations due to
intermittent activation of VGCCs, even in "resting" conditions
(10). Therefore, in a population of GH4C1 cells, considerable VGCC activity may underlie the magnitude of the
Ca2+ entry ascribed to CCE. The extent of VGCC-mediated
Ca2+ entry in resting conditions was explored by comparing
Ca2+ entry in untreated and TG-treated cells. Untreated
cells reveal Ca2+ entry due to spontaneously active VGCCs
along with CCE from passive store depletion due to the cells being in
Ca2+-free buffer. The L-type VGCC blocker,
nimodipine, can then be used to verify the contribution of the
predominant L-type VGCC occurring in
GH4C1 cells. Populations of Fura-2
loaded GH4C1 cells were either untreated or
treated with TG 4 min before the addition of
[Ca2+]o (2 mM). Prior treatment of
the cells with TG may have augmented the [Ca2+]i
rise, giving a peak [Ca2+]i rise of approximately
250 nM (Fig. 4A,
trace a), compared with a peak
[Ca2+]i rise of approximately 220 nM
(Fig. 4A, trace b) in the untreated
cells (to illustrate the two traces more clearly, a running average
(5-s intervals) of each trace has been overlaid on the actual trace).
The magnitude of the [Ca2+]i rise generated by
CCE was clearly discerned in the presence of the VGCC blocker
nimodipine. Addition of nimodipine (1 µM) along with
[Ca2+]o resulted in a greatly reduced
[Ca2+]i rise in the untreated cells
(approximately 125 nM as compared with 220 nM
without nimodipine (Fig. 4A, cf. b
versus d)). The effect of nimodipine on
TG-treated cells was much less drastic, decreasing the peak
[Ca2+]i rise from 250 nM without
nimodipine to 180 nM in the presence of the VGCC blocker
(Fig. 4A, cf. a versus c).
The ability of nimodipine to greatly attenuate the
[Ca2+]i rise generated by Ca2+
addition alone illustrated the prominent, spontaneous VGCC-mediated Ca2+ entry occurring in these cells. Accordingly,
stimulation of ACVIII by the above-mentioned conditions also revealed
the presence of spontaneous VGCC activity. Addition of
[Ca2+]o to GH4C1 cells
maintained in Ca2+-free Krebs buffer resulted in an
approximately 1.5-fold stimulation of ACVIII as compared with the
control, Ca2+-free condition (Fig. 4A,
inset, open bar versus right-hatched bar). Pretreatment of the cells with TG increased the
amount of ACVIII stimulation, resulting in a 2.4-fold increase in
activity (Fig. 4, inset, cross-hatched bar). In
the presence of the VGCC blocker nimodipine, the ability of
[Ca2+]o addition alone to stimulate the cyclase
was completely abolished (Fig. 4A, inset,
left-hatched bar), whereas cells pretreated with TG still
showed a robust regulation of ACVIII (approximately 1.9-fold
stimulation; Fig. 4A, inset, horizontal
striped bar). Thus, basal VGCC activity in resting cells did
contribute significantly to the stimulation of ACVIII. Conversely,
there was no indication of CCE in resting, untreated cells, because the
Ca2+ entry generated by Ca2+ addition was
completely blocked by nimodipine.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 4.
Examination of the presence of CCE in
GH4C1 cells. [Ca2+]i
and cAMP accumulation was determined in GH4C1
cells as described under "Experimental Procedures." A,
[Ca2+]i measurements in populations of
Fura-2-loaded GH4C1 cells maintained in
nominally Ca2+-free Krebs buffer containing IBMX (100 µM). Cells were either untreated (b and
d) or treated with TG (100 nM, 60 s;
a and c) before the addition of
[Ca2+]o (2 mM, 300 s) in the
absence or presence of nimodipine (1 µM, 300 s;
c and d). Trace averages were generated by
averaging 5-s, overlapping data segments and are overlaid on the actual
traces. Inset, cAMP accumulation was measured in
ACVIII-expressing GH4C1 cells maintained in
nominally Ca2+-free Krebs buffer. Control cells (forskolin
stimulation alone, open bars) were compared with untreated
(right-hatched and left-hatched bars) and
TG-treated cells (100 nM; cross-hatched and
horizontal striped bars), in the absence or presence of
nimodipine (1 µM, right-hatched and
horizontal striped bars). B, populations of
Fura-2-loaded GH4C1 cells were
incubated in nominally Ca2+-free Krebs buffer containing
IBMX (100 µM) before the addition of TG (100 nM, 60 s; a and c) and/or KCl
(10 mM, 300 s; a and b), along
with [Ca2+]o (0.5 mM, 300 s).
Inset, cAMP accumulation was measured in ACVIII-expressing
GH4C1 cells maintained in nominally
Ca2+-free Krebs buffer. Control cells (forskolin
stimulation alone, open bar) were compared with TG-treated
(100 nM; right-hatched bar), KCl-treated (10 mM; cross-hatched bar), and TG/KCl-treated
(left-hatched bar) cells in the presence of
[Ca2+]o (0.5 mM).
Asterisks denote significant differences from the TG/KCl
condition (left-hatched bar) as judged by Student's
t test (p < 0.005). C, cAMP
accumulation was measured in ACVIII-expressing
GH4C1 cells maintained in nominally
Ca2+-free Krebs buffer. Control cells (forskolin
stimulation alone, open bar) were compared with untreated
(left-hatched bar), TG-treated (100 nM;
cross-hatched bar), KCl-treated (10 mM,
horizontal striped bar), and TG/KCl-treated (vertical
striped bar) cells in the presence of
[Ca2+]o (0.5 mM). Cells were assayed
in the presence of nimodipine (1 µM), which was added at
the beginning of the 1-min cAMP accumulation assay. The same
fold-stimulation is observed in ACVIII-expressing cells after
activation of CCE or VGCC-mediated Ca2+ entry under basal
conditions, i.e. in the absence of forskolin. Data are
representative of several similar experiments.
|
|
Another method to verify the presence of CCE is to determine whether
the combination of the two Ca2+ entry mechanisms (CCE and
VGCC) yields augmented [Ca2+]i rises and/or
regulation of ACVIII. Populations of GH4C1
cells were treated with TG (Fig. 4B, traces
a and c), followed by depolarization with KCl (10 mM; traces a and b) and addition of
[Ca2+]o (0.5 mM; note that lower
[Ca2+]o values were used to prevent maximal
Ca2+ entry with depolarization alone). TG treatment alone
(trace c) resulted in a modest [Ca2+]i
rise of approximately 250 nM after the addition of [Ca2+]o. Activation of VGCCs with the addition of
[K+]o along with [Ca2+]o
resulted in a [Ca2+]i rise of approximately 400 nM (trace b). Combining the two (TG and
[K+]o (trace a)) resulted in an
augmented [Ca2+]i rise of approximately 510 nM. The combination of CCE and VGCC-mediated
Ca2+ entry also resulted in increased regulation of ACVIII
(Fig. 4B, inset). GH4C1
cells that were pretreated with TG before [Ca2+]o
addition showed a stimulation of ACVIII by approximately 2.4-fold as
compared with control, untreated cells (Fig. 4B,
inset, open bar versus right-hatched
bar). Depolarization of the cells by the addition of
[K+]o along with [Ca2+]o
also resulted in a stimulation of the cyclase, giving an approximately
2.2-fold increase (Fig. 4B, inset,
cross-hatched bar). Combination of the two modes of
Ca2+ entry resulted in an augmented regulation of ACVIII,
yielding an approximately 2.8-fold stimulation (Fig. 4B,
inset, left-hatched bar). In the same experiment
as Fig. 4B, the ability of VGCC-mediated Ca2+
entry activated by KCl addition to regulate the cyclase was also blocked by nimodipine (Fig. 4C). Furthermore, treatment of
the cells with both TG and KCl in the presence of nimodipine resulted in a stimulation of ACVIII that was identical to that seen with TG
treatment alone (Fig. 4C, cross-hatched
versus vertical-striped bars). Therefore, the two
Ca2+ entry mechanisms, CCE and VGCC-mediated
Ca2+ entry, in combination, led to an augmentation in both
the [Ca2+]i rise and the magnitude of the
stimulation of ACVIII produced by either Ca2+ entry
mechanism alone, indicating they are separate Ca2+ entry processes.
The previous results revealed the presence of CCE with the use of
nimodipine to block the spontaneously active VGCCs. It was also shown
that the two Ca2+ entry mechanisms are quite similar in
their ability to regulate ACVIII when the underlying VGCC-mediated
Ca2+ entry is removed from the CCE (cf. Fig. 4,
A versus B, cross-hatched bars). Although the
effects of VGCC-mediated Ca2+ entry and "pure" CCE on
the regulation of the cyclase are similar, the corresponding
[Ca2+]i rises are quite different (Fig.
5, A and B). A
robust [Ca2+]i rise was generated by
VGCC-mediated Ca2+ entry triggered by
[K+]o (Fig. 5A, 10 mM;
trace a), reaching a peak of approximately 700 nM, whereas TG-mediated Ca2+ entry reached a
peak of approximately 250 nM (Fig. 5B,
trace a). In the presence of nimodipine (1 µM), the [Ca2+]i rise generated by
depolarization was almost eliminated (Fig. 5A,
trace b), dropping to approximately 120 nM, whereas TG-mediated Ca2+ entry was
decreased to approximately 170 nM (Fig. 5B,
trace b). This relatively small
[Ca2+]i rise generated by TG treatment in the
presence of nimodipine, "pure" CCE, could still effectively
stimulate ACVIII (cf. Fig. 4C). Therefore, a
[Ca2+]i rise of approximately 170 nM
generated by CCE was as efficacious as the approximately 700 nM [Ca2+]i rise produced by
VGCC-mediated Ca2+ entry in regulating ACVIII.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of nimodipine on TG- and VGCC-mediated
Ca2+ entry. [Ca2+]i was
determined in GH4C1 cells as described under
"Experimental Procedures." A and B,
[Ca2+]i measurements were made in
GH4C1 cells maintained in nominally
Ca2+-free Krebs buffer. A, cells were treated
with KCl/[Ca2+]o (10 mM/2
mM) at 300 s in the absence (a) or presence
(b) of nimodipine (1 µM, 300 s).
B, cells were treated with TG (100 nM, 60 s), followed by the addition of [Ca2+]o (2 mM, 300 s) in the absence (a) or presence
(b) of nimodipine (1 µM, 300 s). Data are
representative of several similar experiments.
|
|
The observation that a modest amount of Ca2+ entry via CCE
was able to stimulate ACVIII to a similar extent as a much more robust VGCC-mediated Ca2+ entry prompted us to investigate whether
Ca2+ release from intracellular stores could also regulate
the exogenously expressed ACVIII. Although TG releases intracellular
Ca2+, the small release occurs over a prolonged period.
Phospholipase C-coupled agonists produce a much more rapid and
significant [Ca2+]i rise. Addition of TRH (100 nM) to populations of GH4C1 cells
maintained in Ca2+-free Krebs buffer resulted in a very
rapid, large [Ca2+]i rise of approximately 500 nM (Fig. 6A).
Intracellular Ca2+ can also be released by Ca2+
ionophores. Treatment of GH4C1 cells incubated in Ca2+-free
Krebs buffer with ionomycin (IM; 2 µM) yielded a rapid
and robust [Ca2+]i rise that reached
approximately 900 nM (Fig. 6B). The ability of
these large [Ca2+]i rises generated by releasing
intracellular Ca2+ with either TRH or IM to stimulate
ACVIII was explored. cAMP accumulation was measured in
GH4C1 cells that were either uninfected (open bars) or infected with the ACVIII-containing virus
(hatched bars) and maintained in Ca2+-free Krebs
buffer before the addition of forskolin along with TRH (100 nM; Fig. 6A, inset) or IM (2 µM; Fig. 6B, inset). Neither TRH or
IM stimulated ACVIII activity as compared with the uninfected control
cells. Therefore, the triggering of a large
[Ca2+]i rise due to the release of
Ca2+ from intracellular stores via either inositol
1,4,5-trisphosphase generation or ionophore-mediated release did
not affect ACVIII.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of Ca2+ release from
intracellular stores on ACVIII expressed in
GH4C1 cells. [Ca2+]i
and cAMP accumulation was determined in GH4C1
cells as described under "Experimental Procedures." A
and B, [Ca2+]i measurements were made
in GH4C1 cells maintained in
Ca2+-free Krebs buffer. Ca2+ was released from
intracellular stores using either TRH (100 nM, 60 s;
A) or IM (2 µM, 60 s; B) with
the resultant [Ca2+]i rises shown.
Insets, cAMP accumulation was measured in either uninfected
(open bars) or ACVIII-infected cells (hatched
bars), as indicated. Cells in Ca2+-free Krebs buffer
were treated with either forskolin/TRH (10 µM/100
nM; A) or forskolin/IM (10 µM/2
µM; B).
|
|
 |
DISCUSSION |
One of the more surprising findings to emerge from the study of
Ca2+-sensitive adenylyl cyclases whether they are
expressed heterologously or endogenously is their strict dependence on
CCE for their regulation in nonexcitable cells (2, 3). Release from
internal stores (4) or Ca2+ entry via ionophore (2, 3) or
triggered by arachidonic acid (7) is without effect. Extremely
little is known about the regulation of Ca2+-sensitive
adenylyl cyclases in excitable cells. In the present study, we have
investigated the regulation of ACVIII by Ca2+ in an
excitable cell line, rat anterior pituitary tumor-derived GH4C1 cells. The study addressed four major
issues: (a) whether Ca2+ entry via VGCCs could
regulate a Ca2+-stimulable adenylyl cyclase, (b)
whether the modest CCE expressed in these cells could regulate the
adenylyl cyclase, (c) whether Ca2+ release from
internal stores could regulate adenylyl cyclase in this excitable cell
line, and (d) whether the relative magnitudes of the
[Ca2+]i rises generated by CCE and VGCCs could
predict the degree of stimulation of the adenylyl cyclase.
Does Ca2+ entry via VGCCs regulate a
Ca2+-stimulable adenylyl cyclase?
Ca2+-sensitive adenylyl cyclases are expressed mainly in
excitable tissues, with the Ca2+-stimulable ACI and ACVIII
found exclusively in neuronal cells (32-34), whereas ACV and ACVI, the
Ca2+-inhibitable isoforms, predominate in cardiac tissue
(35-37). Given the expression pattern of Ca2+-sensitive
adenylyl cyclases and the prevalence of VGCCs in those tissues, we were
surprised at the paucity in the literature on the ability of
VGCC-mediated Ca2+ entry to regulate cAMP accumulation.
Although there is abundant literature on the ability of the
cAMP-signaling cascade to regulate L-type VGCCs (reviewed
in Ref. 38), little has been done to directly address the effect and
the potential feedback of Ca2+ entry by such channels on
adenylyl cyclase activity. An exception was a study showing that
Ca2+ entry through VGCCs inhibited adenylyl cyclase
activity in embryonic chick ventricle myocytes (39). In the case of
Ca2+/calmodulin stimulation of adenylyl cyclase
activity, depolarization of hippocampal CA1 slices by 50 mM
KCl increased cAMP accumulation, which was blocked by calmodulin
antagonists (9). Furthermore, in cultured cerebellar granular cells,
depolarization-induced Ca2+ entry stimulated cAMP
accumulation, which was blocked by nimodipine (8). The current study
has extended these findings in showing that heterologous expression of
a specific Ca2+-stimulable adenylyl cyclase, ACVIII, is
regulated by Ca2+ entry through VGCCs in a clonal cell
line. The potent block of this effect by nimodipine establishes that
the effect is mediated by L-type VGCCs (40).
Does CCE regulate a Ca2+-stimulable adenylyl cyclase in an
excitable cell? The potential role of CCE in excitable cells has been
overshadowed by the more robust Ca2+ entry generated by
VGCCs. Also hindering the study of CCE not only in excitable cells, but
in all cell types, is the uncertainty of the molecular nature of the
channels responsible for CCE. The Drosophila transient
receptor potential protein, which is involved in insect
phototransduction, is increasingly being viewed as a putative CCE
channel (41). A family of mammalian transient receptor potential
protein homologues have now been described, each possessing different
activation and conductance characteristics when heterologously expressed (reviewed in Refs. 42 and 43). Additionally, several of the
mammalian transient receptor potential protein isoforms have been found
in various brain regions, further suggesting a potential role for CCE
in excitable cells (44, 45). One such role for CCE in excitable cells
emerged from the work of Koizumi and Inoue (46), who showed in PC12
cells that caffeine, TG, and cyclopiazoic acid, all agents that release
intracellular Ca2+ and therefore stimulate CCE, evoked
dopamine release. Exocytosis has also been shown to be regulated by CCE
in adrenal chromaffin cells (47). Our findings show that CCE, which
gives rise to a modest increase in [Ca2+]i, was
very effective at stimulating ACVIII. Furthermore, the findings that
CCE augmented the stimulation of ACVIII by VGCC-mediated Ca2+ entry in a manner that was insensitive to nimodipine
establishes the fact that CCE can regulate the cyclase.
Does Ca2+ release from intracellular Ca2+
stores regulate ACVIII in an excitable cell? We have previously shown
an inability of Ca2+ release to regulate
Ca2+-sensitive adenylyl cyclases in nonexcitable cells (4),
and furthermore, we have shown that Ca2+ regulation of
adenylyl cyclases relies totally on Ca2+ entry through CCE
channels (3). In the current study, releasing intracellular
Ca2+ with either phospholipase C-coupled agonists or
ionophore was without effect on ACVIII activity. Similar to our
findings, dopamine release in PC12 cells was insensitive to
Ca2+ release from intracellular stores and in fact depended
on Ca2+ entry (46, 48). Thus we are now inclined to
generalize that Ca2+ release from intracellular stores will
not regulate Ca2+-sensitive adenylyl cyclases, regardless
of cell type.
Does the magnitude of the [Ca2+]i rise generated
by various means predict the amount of stimulation of ACVIII? We have compared the ability of three modes of raising
[Ca2+]i, VGCC-mediated Ca2+ entry,
CCE, and Ca2+ release from internal stores, to stimulate
ACVIII. The [Ca2+]i values achieved by
VGCC-mediated Ca2+ entry and ionophore-mediated
Ca2+ release were both substantial (peak values of
approximately 700 and 900 nM, respectively), with CCE being
much more modest (approximately 250 nmM). However, the
magnitude of these [Ca2+]i rises in no way
predicts the amount of stimulation of ACVIII. The large
[Ca2+]i rise promoted by Ca2+ release
was totally without effect, whereas a similar peak
[Ca2+]i rise generated by VGCC-mediated
Ca2+ entry was very potent at stimulating ACVIII. CCE, the
least effective in terms of producing a large
[Ca2+]i rise, was as efficacious as VGCC-mediated
Ca2+ entry in stimulating ACVIII.
Obviously the inability of the magnitude of different forms of
[Ca2+]i rise to predict subsequent effects on
ACVIII is due to the unresolved spatial information provided by
Fura-2 in population measurements of
[Ca2+]i. One approach to addressing this issue
directly would be to measure the [Ca2+] in the vicinity
of the cyclase by an adenylyl cyclase/aequorin chimera (49), with the
prediction that the chimera would report similar [Ca2+]
in response to VGCC and CCE and far less in response to release from
stores. It is becoming increasingly obvious that the plasma membrane is
not uniform in lipid composition or in the distribution of regulatory
elements. Recent findings indicate that adenylyl cyclases must occur in
cholesterol-rich domains to be susceptible to CCE in nonexcitable cells
(50). In this context, it is also relevant that transient receptor
potential protein 1 has recently been reported in rafts (51). It would
be very interesting to determine whether the same residence in
cholesterol-rich domains would apply to the adenylyl cyclase or to any
of these channels in excitable cells. The nonequivalence in the ability
of VGCC-mediated Ca2+ entry and CCE to regulate ACVIII in
GH4C1 cells may indicate that the adenylyl
cyclase is closer to the CCE channel than the VGCC. It would be
expected, and indeed it has been predicted, that [Ca2+]
of 1 µM would be found up to approximately 50 nm from a
VGCC (52), whereas an equal [Ca2+] would be found
approximately 5-10 nm from the mouth of a CCE channel (53), given the
conductances of L-type and Icrac channels reported in the literature. Furthermore, the moderately high affinity for Ca2+ of Fura-2 makes it likely that the
[Ca2+]i achieved by VGCC in the cytosol is
underestimated (28). Consequently, the VGCC may be even more distant
and in quite a different domain from the adenylyl cyclase.
It seems fair to conclude from these studies that the intimate
relationship that was first demonstrated between CCE channels and
adenylyl cyclase in nonexcitable cells is maintained in excitable cells, even though the adenylyl cyclase is also susceptible to the very
robust VGCC-mediated Ca2+ entry present in these cells.
Whether this association is maintained by colocalization within
cholesterol-rich domains of the plasma membrane, as in nonexcitable
cells (50), or by some additional process remains to be determined.
 |
ACKNOWLEDGEMENTS |
We thank Drs. J. Karpen, T. Rich, and A. Zweifach for their useful comments on the manuscript.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant NS 28389 (to D. M. F. C.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Pharmacology, Box C-236, University of Colorado Health Sciences Center, 4200 E. Ninth Ave., Denver, CO 80262. Tel.: 303-315-8964; Fax: 303-315-7097; E-mail: dermot.cooper@uchsc.edu.
Published, JBC Papers in Press, September 28, 2000, DOI 10.1074/jbc.M006606200
 |
ABBREVIATIONS |
The abbreviations used are:
[Ca2+]i, cytosolic [Ca2+];
CCE, capacitative Ca2+ entry;
ACVIII, adenylyl cyclase type
VIII;
VGCC, voltage-gated calcium channel;
TG, thapsigargin;
[Ca2+]o, extracellular [Ca2+];
[K+]o, extracellular [K+];
TRH, thyrotropin-releasing hormone;
TP, terminal protein;
CMV, cytomegalovirus;
m.o.i., multiplicity of infection;
IBMX, 3-isobutyl-1-methylxanthine;
IM, ionomycin.
 |
REFERENCES |
| 1.
|
Cooper, D. M. F.,
Mons, N.,
and Karpen, J. W.
(1995)
Nature
374,
421-424
|
| 2.
|
Fagan, K. A.,
Mahey, R.,
and Cooper, D. M. F.
(1996)
J. Biol. Chem.
271,
12438-12444
|
| 3.
|
Fagan, K. A.,
Mons, N.,
and Cooper, D. M. F.
(1998)
J. Biol. Chem.
273,
9297-9305
|
| 4.
|
Chiono, M.,
Mahey, R.,
Tate, G.,
and Cooper, D. M. F.
(1995)
J. Biol. Chem.
270,
1149-1155
|
| 5.
|
Burnay, M. M.,
Vallotton, M. B.,
Capponi, A. M.,
and Rossier, M. F.
(1998)
Biochem. J.
330,
21-27
|
| 6.
|
Watson, E. L.,
Wu, Z.,
Jacobson, K. L.,
Storm, D. R.,
Singh, J. C.,
and Ott, S. M.
(1998)
Am. J. Physiol.
274,
C557-C565
|
| 7.
|
Shuttleworth, T. J.,
and Thompson, J. L.
(1999)
J. Biol. Chem.
274,
31174-31178
|
| 8.
|
Cooper, D. M. F.,
Schell, M. J.,
Thorn, P.,
and Irvine, R. F.
(1998)
J. Biol. Chem.
273,
27703-27707
|
| 9.
|
Chetkovich, D. M.,
and Sweatt, J. D.
(1993)
J. Neurochem.
61,
1933-1942
|
| 10.
|
Schlegel, W.,
Winiger, B. P.,
Mollard, P.,
Vacher, P.,
Wuarin, F.,
Zahnd, G. R.,
Wollheim, C. B.,
and Dufy, B.
(1987)
Nature
329,
719-721
|
| 11.
|
Mollard, P.,
Dufy, B.,
Vacher, P.,
Barker, J. L.,
and Schlegel, W.
(1990)
Biochem. J.
268,
345-352
|
| 12.
|
Graham, F. L.,
Smiley, J.,
Russell, W. C.,
and Nairn, R.
(1977)
J. Gen. Virol.
36,
59-72
|
| 13.
|
Schaack, J.,
Langer, S.,
and Guo, X. L.
(1995)
J. Virol.
69,
3920-3923
|
| 14.
|
Jones, N.,
and Shenk, T.
(1978)
Cell
13,
181-188
|
| 15.
|
Chinnadurai, G.,
Chinnadurai, S.,
and Green, M.
(1978)
J. Virol.
26,
195-199
|
| 16.
|
Gomez-foix, A. M.,
Coats, W. S.,
Baque, S.,
Alam, T.,
Gerard, R. D.,
and Newgard, C. B.
(1992)
J. Biol. Chem.
267,
25129-25134
|
| 17.
|
Jordan, M.,
Schallhorn, A.,
and Wurm, F. M.
(1996)
Nucleic Acids Res.
24,
596-601
|
| 18.
|
Pastan, I.,
and Perlman, R. L.
(1971)
Nat. New Biol.
229,
5-7
|
| 19.
|
Engel, D. A.,
Muller, U.,
Gedrich, R. W.,
Eubanks, J. S.,
and Shenk, T.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
3957-3961
|
| 20.
|
Gedrich, R. W.,
and Engel, D. A.
(1995)
J. Virol.
69,
2333-2340
|
| 21.
|
Lee, B. H.,
and Mathews, M. B.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
4481-4486
|
| 22.
|
Whalen, S. G.,
Marcellus, R. C.,
Whalen, A.,
Ahn, N. G.,
Ricciardi, R. P.,
and Branton, P. E.
(1997)
J. Virol.
71,
3545-3553
|
| 23.
|
Smith, D. H.,
Kegler, D. M.,
and Ziff, E. B.
(1985)
Mol. Cell. Biol.
5,
2684-2696
|
| 24.
|
Chinnadurai, G.,
Chinnadurai, S.,
and Brusca, J.
(1979)
J. Virol.
32,
623-628
|
| 25.
|
Evans, T.,
Smith, M. M.,
Tanner, L. I.,
and Harden, T. K.
(1984)
Mol. Pharmacol.
26,
395-404
|
| 26.
|
Fagan, K. A.,
Rich, T. C.,
Tolman, S.,
Schaack, J.,
Karpen, J. W.,
and Cooper, D. M. F.
(1999)
J. Biol. Chem.
274,
12445-12453
|
| 27.
|
Salomon, Y.,
Londos, C.,
and Rodbell, M.
(1974)
Anal. Biochem.
58,
541-548
|
| 28.
|
Grynkiewicz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450
|
| 29.
|
Paulssen, R. H.,
Johansen, P. W.,
Gordeladze, J. O.,
Nymoen, O.,
Paulssen, E. J.,
and Gautvik, K. M.
(1994)
Eur. J. Biochem.
222,
97-103
|
| 30.
|
Mollard, P.,
Theler, J. M.,
Guerineau, N.,
Vacher, P.,
Chiavaroli, C.,
and Schlegel, W.
(1994)
J. Biol. Chem.
269,
25158-25164
|
| 31.
|
Putney, J. W., Jr.
(1986)
Cell Calcium
7,
1-12
|
| 32.
|
Xia, Z. G.,
Refsdal, C. D.,
Merchant, K. M.,
Dorsa, D. M.,
and Storm, D. R.
(1991)
Neuron
6,
431-443
|
| 33.
|
Cali, J. J.,
Zwaagstra, J. C.,
Mons, N.,
Cooper, D. M. F.,
and Krupinski, J.
(1994)
J. Biol. Chem.
269,
12190-12195
|
| 34.
|
Mons, N.,
and Cooper, D. M. F.
(1995)
Trends Neurosci.
18,
536-542
|
| 35.
|
Ishikawa, Y.,
Katsushika, S.,
Chen, L.,
Halnon, N. J.,
Kawabe, J.,
and Homcy, C. J.
(1992)
J. Biol. Chem.
267,
13553-13557
|
| 36.
|
Yoshimura, M.,
and Cooper, D. M. F.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
6716-6720
|
| 37.
|
Krupinski, J.,
Lehman, T. C.,
Frankenfield, C. D.,
Zwaagstra, J. C.,
and Watson, P. A.
(1992)
J. Biol. Chem.
267,
24858-24862
|
| 38.
|
Rossie, S.
(1999)
Adv. Second Messenger Phosphoprotein Res.
33,
23-48
|
| 39.
|
Yu, H. J.,
Ma, H.,
and Green, R. D.
(1993)
Mol. Pharmacol.
44,
689-693
|
| 40.
|
Furukawa, T.,
Yamakawa, T.,
Midera, T.,
Sagawa, T.,
Mori, Y.,
and Nukada, T.
(1999)
J. Pharmacol. Exp. Ther.
291,
464-473
|
| 41.
|
Putney, J. W.,
and McKay, R. R.
(1999)
Bioessays
21,
38-46
|
| 42.
|
Zhu, X.,
Jiang, M.,
Peyton, M.,
Boulay, G.,
Hurst, R.,
Stefani, E.,
and Birnbaumer, L.
(1996)
Cell
85,
661-671
|
| 43.
|
Harteneck, C.,
Plant, T. D.,
and Schultz, G.
(2000)
Trends Neurosci.
23,
159-166
|
| 44.
|
Otsuka, Y.,
Sakagami, H.,
Owada, Y.,
and Kondo, H.
(1998)
Tohoku J. Exp. Med.
185,
139-146
|
| 45.
|
Philipp, S.,
Hambrecht, J.,
Braslavski, L.,
Schroth, G.,
Freichel, M.,
Murakami, M.,
Cavalie, A.,
and Flockerzi, V.
(1998)
EMBO J.
17,
4274-4282
|
| 46.
|
Koizumi, S.,
and Inoue, K.
(1998)
Biochem. Biophys. Res. Commun.
244,
293-297
|
| 47.
|
Fomina, A. F.,
and Nowycky, M. C.
(1999)
J. Neurosci.
19,
3711-3722
|
| 48.
|
Taylor, S. C.,
and Peers, C.
(1999)
J. Neurochem.
73,
874-880
|
| 49.
|
Nakahashi, Y.,
Nelson, E.,
Fagan, K. A.,
Gonzales, E.,
Guillou, J. L.,
and Cooper, D. M. F.
(1997)
J. Biol. Chem.
272,
18093-18097
|
| 50.
|
Fagan, K. A.,
Smith, K. E.,
and Cooper, D. M. F.
(2000)
J. Biol. Chem.
275,
26530-26537
|
| 51.
|
Lockwich, T. P.,
Liu, X. B.,
Singh, B. B.,
Jadlowiec, J.,
Weiland, S.,
and Ambudkar, I. S.
(2000)
J. Biol. Chem.
275,
11934-11942
|
| 52.
|
Naraghi, M.,
and Neher, E.
(1997)
J. Neurosci.
17,
6961-6973
|
| 53.
|
Zweifach, A.,
and Lewis, R. S.
(1995)
J. Gen. Physiol.
105,
209-226
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Tsujikawa, Y. Song, M. Watanabe, H. Masumiya, S. A. Gupte, R. Ochi, and T. Okada
Cholesterol depletion modulates basal L-type Ca2+ current and abolishes its -adrenergic enhancement in ventricular myocytes
Am J Physiol Heart Circ Physiol,
January 1, 2008;
294(1):
H285 - H292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Willoughby and D. M. F. Cooper
Organization and Ca2+ Regulation of Adenylyl Cyclases in cAMP Microdomains
Physiol Rev,
July 1, 2007;
87(3):
965 - 1010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Buser, E. K. Gass-Handel, S. L. Wyszomierski, W. Doppler, S. A. Leonhardt, J. Schaack, J. M. Rosen, H. Watkin, S. M. Anderson, and D. P. Edwards
Progesterone Receptor Repression of Prolactin/Signal Transducer and Activator of Transcription 5-Mediated Transcription of the {beta}-Casein Gene in Mammary Epithelial Cells
Mol. Endocrinol.,
January 1, 2007;
21(1):
106 - 125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Singaravelu, C. Lohr, and J. W. Deitmer
Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes.
J. Neurosci.,
September 13, 2006;
26(37):
9579 - 9592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Gonzalez-Iglesias, Y. Jiang, M. Tomic, K. Kretschmannova, S. A. Andric, H. Zemkova, and S. S. Stojilkovic
Dependence of Electrical Activity and Calcium Influx-Controlled Prolactin Release on Adenylyl Cyclase Signaling Pathway in Pituitary Lactotrophs
Mol. Endocrinol.,
September 1, 2006;
20(9):
2231 - 2246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Willoughby and D. M. F. Cooper
Ca2+ stimulation of adenylyl cyclase generates dynamic oscillations in cyclic AMP
J. Cell Sci.,
March 1, 2006;
119(5):
828 - 836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Crossthwaite, A. Ciruela, T. F. Rayner, and D. M. F. Cooper
A Direct Interaction between the N Terminus of Adenylyl Cyclase AC8 and the Catalytic Subunit of Protein Phosphatase 2A
Mol. Pharmacol.,
February 1, 2006;
69(2):
608 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Willoughby, N. Masada, A. J. Crossthwaite, A. Ciruela, and D. M. F. Cooper
Localized Na+/H+ Exchanger 1 Expression Protects Ca2+-regulated Adenylyl Cyclases from Changes in Intracellular pH
J. Biol. Chem.,
September 2, 2005;
280(35):
30864 - 30872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brini, M. Miuzzo, N. Pierobon, A. Negro, and M. C. Sorgato
The Prion Protein and Its Paralogue Doppel Affect Calcium Signaling in Chinese Hamster Ovary Cells
Mol. Biol. Cell,
June 1, 2005;
16(6):
2799 - 2808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Dyer, Y. Liu, I. P. de la Huerga, and C. W. Taylor
Long Lasting Inhibition of Adenylyl Cyclase Selectively Mediated by Inositol 1,4,5-Trisphosphate-evoked Calcium Release
J. Biol. Chem.,
March 11, 2005;
280(10):
8936 - 8944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Crossthwaite, T. Seebacher, N. Masada, A. Ciruela, K. Dufraux, J. E. Schultz, and D. M. F. Cooper
The Cytosolic Domains of Ca2+-sensitive Adenylyl Cyclases Dictate Their Targeting to Plasma Membrane Lipid Rafts
J. Biol. Chem.,
February 25, 2005;
280(8):
6380 - 6391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Murthy, H. Zhou, J. Huang, and S. N. Pentyala
Activation of PLC-{delta}1 by Gi/o-coupled receptor agonists
Am J Physiol Cell Physiol,
December 1, 2004;
287(6):
C1679 - C1687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Antoni, A. A. Sosunov, A. Haunso, J. M. Paterson, and J. Simpson
Short-Term Plasticity of Cyclic Adenosine 3',5'-Monophosphate Signaling in Anterior Pituitary Corticotrope Cells: The Role of Adenylyl Cyclase Isotypes
Mol. Endocrinol.,
April 1, 2003;
17(4):
692 - 703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Cioffi, T. M. Moore, J. Schaack, J. R. Creighton, D. M.F. Cooper, and T. Stevens
Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase
J. Cell Biol.,
June 24, 2002;
157(7):
1267 - 1278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Sunahara and R. Taussig
Isoforms of Mammalian Adenylyl Cyclase: Multiplicities of Signaling
Mol. Interv.,
June 1, 2002;
2(3):
168 - 184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Bootman, P. Lipp, and M. J. Berridge
The organisation and functions of local Ca2+ signals
J. Cell Sci.,
March 8, 2002;
114(12):
2213 - 2222.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|